Study population We studied three independent cohorts of patients with NSCLC who were treated with PD-1-based immunotherapies in the advanced or metastatic setting. The clinical characteristics of the cohorts are presented in Supplementary Tables 1 and 2. The first cohort, which served as the training cohort, was obtained from the Yale Cancer Center (New Haven). This cohort comprises 113 tissue …
Read More »Spatial signatures for predicting immunotherapy outcomes using multi-omics in non-small cell lung cancer
